This deal strengthens SteinCares’ leadership in the biosimilar segment across Latin America with this treatment for diverse ophthalmological diseases. The partnership will result in significant cost savings for institutions in the region by providing access to a...
This strategic partnership brings an innovative intravenous iron replacement therapy to Ecuador, the Dominican Republic, Guatemala, Chile, Panama and soon in Costa Rica — offering a safe and effective treatment alternative for patients. The expanded collaboration is a...
Strategic alliance drives growth, launching Metoject in Costa Rica, Dominican Republic, Guatemala and Panama, following successful commercialization in Colombia, Chile, and Ecuador. This expanded collaboration highlights SteinCares’ strategic role as a bridge between...
The company plans to launch 14 products in Brazil, targeting a potential market of USD 2 billion, expanding access to high-complexity treatments in key therapeutic areas, expecting to generate over USD 130 million in sales within the next 4 years. Through strategic...
CStone will receive upfront, regulatory and commercial milestone payments, and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries. This marks CStone’s third major global commercialization partnership for...
The agreement includes the exclusive marketing and distribution of Oramorph® a novel morphine oral solution with presence in over 35 countries worldwide in Ecuador, Brazil, and Mexico. This alliance reinforces SteinCares’ role as a bridge between Latin America’s...
